Investments
32Portfolio Exits
8About Martin Varsavsky
Martin Varsavsky is an Argentine/Spanish entrepreneur, founder of seven companies in the past 20 years.In 1984, while still in college, Martin Varsavsky started his first business, Urban Capital Corporation, one of the early leaders of the loft movement in downtown Manhattan. This was soon followed in 1986 by Medicorp Services, a Canadian biotechnology company, a pioneer in AIDS and PSA testing. His third business, Viatel Ltd., Martin's first venture into the world of telecom, was founded in 1990. This company is best known for inventing call back and building the first pan European fiber optic network ahead of liberalization.MV's best-known ventures were founded during the last decade. In 1998 MV started Jazztel Telecomunicaciones (Jazztel), Spain's second largest publicly traded telecom operator. In 1999 he founded Ya.com, Spain's third largest internet web site/DSL provider that includes the second largest Spanish language web agency www.viajar.com. But not all of MV's companies were successful. In 2000 he started Germany's largest ASP, Einsteinet, and the company was sold in 2003 at no return to him or investors.Martin's current venture is FON, an innovative WiFi start up founded in February 2006 and headquartered in Madrid, Spain, with some 100 employees located around the world. FON's mission is to make WiFi universal and free by creating a unified global community of members who share WiFi. The FON Community already has close to 700,000 members and has become the world's largest WiFi community.FON has raised more than 30M Euro in financing from among others Skype, Google, Index Ventures, Sequoia Capital and BT. These leading Internet and communications companies have shown the industry's support for FON's vision and business model.(source: http://english.martinvarsavsky.net)
Martin Varsavsky Headquarter Location
Latest Martin Varsavsky News
Feb 20, 2022
Tympa Health Technologies , a London, UK-based digital health company, raised $8M in Seed funding. The round was led by Maurice Ferre and Arjun Desai with participation from Jim Breyer, Anil Sethi, Martin Varsavsky, Carlos Gallardo, Fred Moll, Elan Katz, Manny Kadre and Imran Hakim. TympaHealth will also be appointing Arjun Desai and Karin Ajmani to their board of directors. The company intends to use the funds to accelerate its expansion across the U.K., Europe & U.S. Founded by CEO Dr. Krishan Ramdoo, TympaHealth is a digital health company that uses patented technology to allow for comprehensive hearing health assessments to be performed in point-of-care settings, enabling earlier disease detection and access to cost-effective care. By combining proprietary hardware and AI-enabled software, TympaHealth created a hearing assessment platform available to patients outside traditional primary or secondary care settings, like pharmacies, retail stores, and assisted living facilities. Fully portable and intuitive, within a few minutes, the point of care tool provides patients (and their providers) with the information to detect disease and manage their hearing health through high-resolution ear drum visualization, ear wax removal and a real-time screening audiogram. The system is CE marked and FDA registered. FinSMEs 20/02/2022
Martin Varsavsky Investments
32 Investments
Martin Varsavsky has made 32 investments. Their latest investment was in TympaHealth as part of their Seed VC on February 2, 2022.
Martin Varsavsky Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/17/2022 | Seed VC | TympaHealth | $8M | Yes | 8 | |
10/21/2021 | Series A | Pomelo | $35M | Yes | Angela Strange, Biz Stone, BoxGroup, Clocktower Technology Ventures, Eric Glyman, Gilgamesh Ventures, Greyhound Capital, Index Ventures, Insight Partners, Itai Damti, Jacqueline Reses, Karim Atiyeh, Max Levchin, Maximilian Tayenthal, Monashees+, QED Investors, SciFi VC, Tiger Global Management, and William Hockey | 9 |
6/3/2021 | Angel | NUE Life Health | $3.3M | Yes | 4 | |
1/24/2020 | Seed | |||||
6/3/2019 | Series C |
Date | 2/17/2022 | 10/21/2021 | 6/3/2021 | 1/24/2020 | 6/3/2019 |
---|---|---|---|---|---|
Round | Seed VC | Series A | Angel | Seed | Series C |
Company | TympaHealth | Pomelo | NUE Life Health | ||
Amount | $8M | $35M | $3.3M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Angela Strange, Biz Stone, BoxGroup, Clocktower Technology Ventures, Eric Glyman, Gilgamesh Ventures, Greyhound Capital, Index Ventures, Insight Partners, Itai Damti, Jacqueline Reses, Karim Atiyeh, Max Levchin, Maximilian Tayenthal, Monashees+, QED Investors, SciFi VC, Tiger Global Management, and William Hockey | ||||
Sources | 8 | 9 | 4 |
Martin Varsavsky Portfolio Exits
8 Portfolio Exits
Martin Varsavsky has 8 portfolio exits. Their latest portfolio exit was Busuu on January 13, 2022.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.